Wojtek Mydlarz, M.D., is the director of Johns Hopkins Head and Neck Surgery for the National Capitol Region, as well as an assistant professor in the Department of Otolaryngology–Head and Neck Surgery for Johns Hopkins University School of Medicine. Dr. Mydlarz is board certified in otolaryngology by the American Board of Otolaryngology.
Dr. Mydlarz specializes in the treatment of benign and malignant tumors of the head and neck, including the upper aerodigestive tract, salivary glands, thyroid, skin and soft tissue.
Dr. Mydlarz received his medical degree from The Johns Hopkins University School of Medicine and completed his internship and residency in otolaryngology-head and neck surgery at Johns Hopkins Hospital. He also completed a Science of Clinical Investigation Training Program at Johns Hopkins Bloomberg School of Public Health, as well as specialized fellowship training in head and neck surgical oncology at the renowned M.D. Anderson Cancer Center. Dr. Mydlarz went on to serve as a clinical specialist in the Department of Head and Neck Surgery at M.D. Anderson Cancer Center before becoming clinical faculty at Johns Hopkins. He also previously served as the director of the Otolaryngology Consulting Service for Johns Hopkins.
Dr. Mydlarz has earned the Helen Taussig Professionalism and Career Development Award by Johns Hopkins School of Medicine, as well as research training fellowships from the National Institutes of Health.
Dr. Mydlarz is a member of the Maryland Society of Otolaryngology, the Washington Metropolitan Area Otolaryngology Society, the American Medical Association, and the American Head and Neck Society, where he serves on various committees. He is also a fellow of the American Academy of Otolaryngology-Head and Neck Surgery, as well as the American College of Surgeons.
Dr. Mydlarz is a medical officer, as well as a clinical and research collaborator in the Head and Neck Surgery Branch of the National Institutes of Health. His research interests include evaluating both surgical and non-surgical treatment outcomes in head and neck cancer patients. He is also interested in the complex molecular biology of head and neck cancer, and potential clinical applications of novel targeted cancer therapies. Dr. Mydlarz has contributed to numerous publications, articles, book chapters and lectures. He serves on the editorial board for Oral Oncology and is a journal reviewer for Oral Oncology, Head and Neck, The Laryngoscope and JAMA-Otolaryngology.